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Objective. Smoking plays a major role in deficiencies of the vascular system, and seems to have consequences for the
treatment of cardiovascular diseases. We hypothesized that smokers have a higher mortality and more complications after
endovascular abdominal aortic aneurysm surgery than non-smokers.
Methods. We assessed mortality and complications of 3270 patients who underwent endovascular abdominal aortic
aneurysm surgery in Europe between January 1994 and July 2001. Survival and (post) operative complications were
assessed by smoking status.
Results. Mortality did not significantly differ between smokers and non-smokers. Smokers had a higher number of intra-
operative additional procedures, but a lower number of late endoleaks in comparison to non-smokers. In addition, smokers
had a reduced risk of late type II endoleaks in comparison with non-smokers.
Conclusion. There seems to be no significant difference in endovascular abdominal aortic aneurysm surgery outcome
between smokers and non-smokers, although there were significant differences in intra-operative additional procedures and
late endoleaks.
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Introduction
Smoking is a major risk factor for cardiovascular
morbidity and mortality. It triples the risk of dying
from heart disease among middle-aged men and
women.1 Since 1960, the percentage of smokers has
decreased from about 90% to 30–35%. Over the past
few years, this percentage has not decreased further,
while the percentage of juvenile smokers has even
shown an increase.2,3
Smoking plays a major role in deficiencies of the
vascular system such as arteriosclerosis of the extre-
mities, arterial embolism, carotid artery disease,
thrombophlebitis, and abdominal aortic aneurysm.
Particularly, smoking is related to abdominal aortic
aneurysm expansion and rupture.4,5 Acute effects,
physiological, metabolic, and pathological conse-
quences of smoking are observed.6 – 19 The beneficial
effects of smoking cessation have also been
reported.20 – 22
Treatment of cardiovascular diseases ranges from
exercise and medication to vascular and endovascular
surgery. Smoking seems to influence treatment out-
come. Researchers suggest that the poorer survival of
women as compared to men after abdominal aortic
aneurysm surgery could be attributed to greater
cardiovascular co-morbidity, because evidence from
screening studies suggests that women with abdomi-
nal aortic aneurysm are more likely to have been
smokers than men.23 – 25 Furthermore, a greater risk of
death, Q-wave infarction, and re-operations as well as
a lower rate of repeated revascularization after
vascular surgery are reported for smokers as com-
pared to non-smokers.26,27 Interestingly, a recently
published study found that a lower rate of subsequent
revascularization in smokers was partly explained by
a reduced sensitivity to re-stenosis in smokers and
their greater reluctance to seek medical attention.28
The consequences of smoking on endovascular
abdominal aortic aneurysm surgery outcome are
unclear. Elevated blood pressure and morphological
changes as a consequence of smoking, such as arterial
wall changes29 (i.e. thinning or thickening) and
increased arterial wall stiffness, are important aspects,
especially for endovascular surgery. Since smoking
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may lead to changes that are closely related to
abdominal aortic aneurysm morphology, smoking
may have effects on endovascular aneurysm repair.
We hypothesized that smokers have a higher mortality
and more complications after endovascular abdominal
aortic aneurysm surgery than non-smokers.
Methods
Study population
Patient data were obtained from the EUROSTAR
registry (EUROpean collaborators on Stent-graft Tech-
niques for abdominal aortic Aneurysm Repair). This
multi-centre registry comprises 107 collaborating
European institutions. The study population included
3270 patients who underwent endovascular abdomi-
nal aortic aneurysm surgery between January 1994
and July 2001.The study population was divided into
two groups according to the Society for Vascular
Surgery/International Society for Cardiovascular Sur-
gery (SVS/ISCVS) smoking risk score at the time of
enrolment.30 The group of non-smokers consisted of
patients who did not smoke at the time of enrolment
(i.e. both patients who never smoked or who had not
smoked in the previous 10 years and patients who
smoked in the previous 10 years: SVS-ISCVS risk
score-0 or 1). The group of smokers consisted of
patients who did smoke at the time of enrolment (i.e.
both patients who smoke less than one packet per day
and patients who smoke more than one packet per
day: SVS-ISCVS risk score-2 or 3). The majority of the
data was collected prospectively (91%). The methods
have been reported in several other reports.31,32
Data assessment
Baseline information collected and documented in the
EUROSTAR registry included demographic data,
clinical characteristics, vascular morphology, and
relevant concomitant diseases according to the
SVS/ISCVS guidelines.30 Operative data included
type of endograft, operative technical details and the
occurrence of complications. Information collected
during follow-up consisted of complications and
clinical events determined by physical examination
or imaging techniques: CT, angiography, MRI or
Duplex. The follow-up protocol included visits at 1,
3, 6, 12, 18 and 24 months after the procedure and
yearly thereafter.
Outcome variables
The primary outcome variable was mortality. Second-
ary outcome variables were early and late compli-
cations. Early mortality/complications are defined as
death or events occurring within the first 30 post-
operative days or until discharge in case of prolonged
hospital stay. Late mortality/complications are
defined as death or events after the first 30 post-
operative days and after discharge.
Statistical analysis
The results are expressed as mean (SD) or as
frequencies (percentages). The differences between
groups in early outcome measures were assessed
using the x2-test or the Fisher exact test for categorical
data and continuous data by the t-test, or the rank-test
for non-parametric variables. Late outcome (after the
first 30-days) measures were analysed using the
Kaplan–Meier method. Differences in survival were
assessed for significance by means of the log-rank test.
Multivariate Cox proportional hazards models were
used to examine the relationship of smoking to late
events, adjusted for baseline characteristics, including
age, gender, morphological data, pre-existing co-
morbidity, device, year of operation and operating
team experience. A P value of less than 0.01 was
considered statistically significant.
Results
Baseline clinical characteristics
Among the 3270 patients who underwent endovascu-
lar abdominal aortic aneurysm surgery, 853 (26%)
were smokers (Table 1). Overall, smokers were
younger in age ðP , 0:01Þ; had less baseline cardiac
dysfunction ðP , 0:01Þ; and abnormal pulmonary
status ðP , 0:01Þ: Furthermore, smokers had less
often significant angulation of the aneurysm ðP ,
0:01Þ in comparison to non-smokers. However,
regression analysis showed a less significant relation-
ship of smoking to aneurysm angulation ðP , 0:05Þ
after correction for age. Eight patients were lost to
follow-up within the first 30 postoperative days and 16
patients were lost to follow-up after this period.
Operative data and early outcome
Early mortality did not significantly differ ðP ¼ 0:558Þ
between non-smokers (3%) and smokers (2%).
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Smoking was associated with more intra-operative
additional procedures (39% in smokers versus 32% in
non-smokers, P , 0:01) (Table 2). The increased
number of intra-operative additional procedures con-
sisted mainly of an increased number of PTA or stents
for stenosis (19% in smokers versus 15% in non-
smokers, P , 0:01).
Smokers did not significantly differ from non-
smokers in their number of early endoleaks,33 conver-
sions, ruptures, and other complications.
Late outcome
Median follow-up duration was 12 months for both
smokers (range: 0–84) and non-smokers (range: 0–72).
Late mortality did not significantly differ between
smokers and non-smokers (Table 3, Fig. 1).
Unadjusted analyses (Table 3, Fig. 2) showed fewer
late endoleaks among smokers than among non-
smokers (15% versus 20%, P , 0:01). Additional
analysis revealed that the number of late type II
endoleaks was significantly lower in smokers com-
pared with non-smokers (7% versus 11%, P , 0:01).
Adjusted for all baseline variables, smokers had
reduced risk for late type II endoleaks than non-
smokers (Hazard ratio: 0.64; 95% confidence interval:
0.5 to 0.9). The association between smoking and late
type II endoleaks also remained unchanged after
correction for preoperative patency of IMA or the
hypogastrics and also after operative embolisation of
IMA lumbar or hypogastric arteries.
Table 1. Baseline clinical characteristics
Non-
smokers
ðn ¼ 2417Þ
Smokers
ðn ¼ 853Þ
P value*
No. (%) No. (%)
Age
# 60 158 7 138 16 ,0.01
61–70 786 33 339 40
71–80 1187 49 315 37
. 80 286 12 61 7
Sex
Male 2221 92 806 95
Female 196 8 47 5
ASA class†
I 167 7 102 12
II 904 39 260 32
III 1120 48 383 46
IV 150 6 79 10
Diabetes 239 10 98 12
Hypertension 1468 61 491 58
Hyperlipemia 891 38 334 40
Cardiac dysfunction 1516 63 440 52 ,0.01
Carotid disease 376 16 147 18
Renal dysfunction 459 19 131 16
Pulmonary dysfunction 877 37 391 47 ,0.01
Previous laparotomy 678 28 245 29
Obesity 563 23 220 26
Infrarenal aorta (a.) diameter (mm)
, 23 1080 48 373 48
¼ 23 1181 52 412 52
Length lower renal a. and neck a. (mm)
, 25 1041 46 341 44
$ 25 1210 54 431 56
Angulation aortic neck 561 23 186 22
Aneurysm diameter (mm
, 55 1042 44 400 48
¼ 55 1318 56 430 52
Angulation aneurysm 302 12 74 9 ,0.01
Right common iliac artery diameter (mm)
, 12 702 37 266 39
$ 12 1181 63 424 61
Angulation right Iliac 862 36 282 33
Left common iliac artery diameter (mm)
, 12 736 39 283 41
$ 12 1130 61 405 59
Angulation left iliac 977 40 334 39
*P value was determined by the x2 test or Fisher exact test for
categorical data and the t test for continuous data.
†ASA I, healthy patient for elective operation; ASA II, patient with
mild systemic disease, limits activity but is not incapacitating; ASA
III, patient with severe systemic disease that is constant threat of life,
limits activity but is not incapacitating; ASA IV, patient with
incapacitating systemic disease that is a constant threat of life.
Table 2. Operative data and early outcome
Non-
smokers
ðn ¼ 2417Þ
Smokers
ðn ¼ 853Þ
P value*
No. (%) No. (%)
Additional procedures
Overall 769 32 332 39 ,0.01
PTA/stent for stenosis 351 15 158 19 ,0.01
Endarterectomy 42 2 15 2
Iliofemoral bypass 21 1 7 1
Crossover bypass 84 3 32 4
Uncovered stent 67 3 32 4
Other 347 14 141 17
Complications
Device related 202 8 72 8
Arterial 95 4 44 5
Systemic 371 15 112 13
Endoleaks†
Overall 453 19 131 15
Type I proximal 89 4 24 3
Type I distal 87 4 19 2
Type II 217 9 64 8
Type III 68 3 23 3
Conversion 43 2 16 2
Rupture 1 0 0 0
Death 68 3 21 2
*P value was determined by the x2 test or Fisher exact test for
categorical data and the t test for continuous data.
†Endoleaks have been categorized according to the May–White
classification.33.
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Fig. 1. Survival in patients who underwent endovascular AAA surgery stratified by smoking status.
Table 3. Late outcome
Non-smokers ðn ¼ 2417Þ Smokers ðn ¼ 853Þ Unadjusted P value* Adjusted P value†
No. (%) No. (%)
Secondary interventions 306 13 126 15
Endoleaks‡
Overall 488 20 128 15 ,0.01 ,0.01
Type I proximal 71 3 20 2
Type I distal 138 6 40 5
Type II 267 11 59 7 ,0.01 ,0.01
Type III 117 5 29 3
Conversion 40 2 26 3
Rupture 17 1 6 1
Death 185 8 62 7
*P value was determined by the Kaplan–Meier analysis and the log-rank test.
†Adjusted for all baseline characteristics (Cox’s proportional hazards model).
‡Endoleaks have been categorized according to the May–White classification.33.
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There were no significant differences in numbers of
late conversions, ruptures and secondary interven-
tions in smokers compared with non-smokers.
Discussion
About a quarter of the patients who underwent
elective endovascular aneurysm repair smoked at the
time of enrolment. Smokers were more often younger,
and had more often normal cardiac and abnormal
pulmonary status. The number of intra-operative
additional procedures was higher in smokers. A
lower prevalence of late endoleaks was observed in
smokers compared with non-smokers. Furthermore,
no statistically significant differences were found
between smokers and non-smokers in mortality,
conversion rate and other complications. For ruptures,
although a total of 24 ruptures was reported, this
number might be too small to detect differences
between the groups.
This study was the first large investigation on the
impact of smoking on endovascular surgery outcome.
Previous studies have investigated the impact of
smoking on vascular surgery outcome. One study on
the effect of smoking on long-term outcome after
successful percutaneous coronary revascularization
showed that smokers were at greater risk of Q-wave
infarction and death after surgery than non-smokers.26
In addition, this study reported a higher risk for
Fig. 2. Freedom from endoleak in endovasular AAA patients stratified by smoking status.
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non-smokers than for smokers and former smokers to
undergo additional percutaneous coronary pro-
cedures or coronary bypass surgery. Another study
reported that smokers were at greater risk for
myocardial infarction and re-operation after coronary
bypass surgery than former smokers and non-smo-
kers.27 In our study no significant differences were
found in the number of deaths and re-operations in
smokers compared to non-smokers. The relationship
between smoking and aneurysm angulation seems to
be merely the result of the presentation of smokers at
an early age, since regression analysis showed a less
significant relationship after correction for age.
We found a higher number of PTA and stents for
stenosis during operation in smokers. This is in
accordance with the results of previous studies and
might be explained by metabolic and pathological
changes as a consequence of smoking, such as
increased platelet aggregation, consistent changes in
serum lipoproteins, arterial wall thickening, and
ultrastructural changes in aortic endothelial cells,
which are thought to be primary initiating events of
atherosclerosis.14 – 19
Finally, we found a lower prevalence of late
endoleaks in smokers compared with non-smokers.
This difference did not reflect the number of pre-
operative patent IMA, since the association remained
unchanged after correction for IMA hypogastric
patency. This might be explained by an increased
platelet aggregation as a consequence of smoking,34 by
which the thrombotic potential increases and the risk
of endoleaks, especially type II endoleaks, may
decrease in smokers.
Type II endoleaks occur when there is persistent
blood flow from patent lumber arteries, the inferior
mesenteric artery, or other collateral vessels. Early type
II endoleaks resolve spontaneously in approximately
50% of patients. If the endoleak does not resolve it may
be treated by embolisation of the collateral vessels
filling the aneurysm sac or by placement of metal coils
in the aneurysm sac. Although type II endoleaks are
not innocuous, it does not lead directly to more
mortality or life threatening complications.
One limitation of our study was that the self-
reported status of smoking was not confirmed by
biochemical tests. In the literature it is found that
patients tend to underreport their smoking habits.35 If
a substantial proportion of the non-smokers were
smokers, this could bias risk estimate for late
endoleaks among smokers. One study that used both
self-reported smoking status and the serum creatinine
level reported a significant association between serum
creatinine and postoperative death after elective
surgical repair of abdominal aortic aneurysm.36 No
association was found between smoking status and
late outcome.
In conclusion, smoking behaviour is found in about
a quarter of the patients who underwent endovascular
abdominal aortic aneurysm surgery. Smoking is
associated with more intra-operative additional pro-
cedures and less type II endoleaks after the first 30
postoperative days. Smoking seems to have no
consequences for the technical outcome in patients
who underwent endovascular abdominal aortic aneur-
ysm surgery. Our conclusion is, however, irrelevant to
clinical practice since there can be no vascular surgeon
in the world who would recommend that patients
under their care should continue to smoke. The risks of
smoking are well established. Smoking has an adverse
effect on patients in many ways but the technical
outcome of endovascular surgery is unlikely to be one
of them.
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